Skip to content

Cecil Long, M.D.

NPI 1922175322ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Birmingham, AL

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in Birmingham, Alabama, licensed in AL, with an NPI issued in November 2006. Part D covered 37 prescriptions written in 2024, 89% of them generic. Ferring Pharmaceuticals Inc. reported $27.80 in payments in 2025, mostly food and beverage.

Overview

NPI1922175322
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedNov 29, 2006
Last updated in NPPESMar 17, 2018

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)37 · 42 30-day fills
Total drug cost$5,349
Generic share89% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$27.80 · 1 payment from 1 company
  • 2024$188.59 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$27.801

What the 2025 payments were for

  • Food and Beverage$27.80 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Birmingham

All 19 Obstetrics & Gynecology, Reproductive Endocrinology providers in Birmingham · All Obstetrics & Gynecology, Reproductive Endocrinology providers in Alabama